Table 3 Distribution of samples according to BP and kidney function [counts and (percentages)]
| Â | Piperacillin-tazobactam | Meropenem | ||||
|---|---|---|---|---|---|---|
0.25Â mg/L | 8Â mg/L | 16Â mg/L | BP unknown | 2Â mg/L | BP unknown | |
(N = 10) | (N = 808) | (N = 257) | (N = 817) | (N = 631) | (N = 297) | |
ARC | 4 (40.0) | 168 (20.8) | 59 (23.0) | 149 (18.2) | 126 (20.3) | 52 (17.5) |
Stable kidney function | 4 (40.0) | 335 (41.5) | 115 (44.8) | 354 (43.3) | 274 (44.1) | 139 (46.8) |
AKI I | 2 (20.0) | 110 (13.6) | 32 (12.5) | 90 (11.0) | 63 (10.1) | 34 (11.5) |
AKI II | 0 (0.0) | 70 (8.6) | 25 (9.7) | 93 (11.4) | 41 (6.6) | 29 (9.8) |
AKI III | 0 (0.0) | 33 (4.1) | 1 (0.4) | 29 (3.6) | 17 (2.7) | 7 (2.4) |
RRT | 0 (0.0) | 92 (11.4) | 25 (9.7) | 102 (12.5) | 100 (16.1) | 36 (12.1) |